Citadel Advisors
BHC icon

Citadel Advisors’s Bausch Health BHC Stock Holding History

Citadel Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.81M Sell
520,500
-39,200
-7% -$235K ﹤0.01% 5405
2025
Q4 		$3.89M Buy
559,700
+8,200
+1% +$53.9K ﹤0.01% 4709
2025
Q3 		$3.56M Buy
551,500
+281,100
+104% +$1.92M ﹤0.01% 4980
2025
Q2 		$1.8M Sell
270,400
-1,423,700
-84% -$7.32M ﹤0.01% 5902
2025
Q1 		$11M Sell
1,694,100
-1,510,200
-47% -$10.8M ﹤0.01% 2729
2024
Q4 		$25.8M Sell
3,204,300
-279,200
-8% -$2.3M ﹤0.01% 1893
2024
Q3 		$28.4M Buy
3,483,500
+150,700
+5% +$993K 0.01% 1725
2024
Q2 		$23.2M Sell
3,332,800
-1,510,600
-31% -$11.4M ﹤0.01% 1847
2024
Q1 		$51.4M Buy
4,843,400
+2,800
+0.1% +$24.5K 0.01% 1186
2023
Q4 		$38.8M Sell
4,840,600
-276,100
-5% -$2.01M 0.01% 1379
2023
Q3 		$42.1M Buy
5,116,700
+124,300
+2% +$1.07M 0.01% 1213
2023
Q2 		$39.9M Buy
4,992,400
+4,510,500
+936% +$33.3M 0.01% 1230
2023
Q1 		$3.9M Sell
481,900
-19,700
-4% -$158K ﹤0.01% 4211
2022
Q4 		$3.15M Sell
501,600
-259,600
-34% -$1.81M ﹤0.01% 4679
2022
Q3 		$5.25M Sell
761,200
-721,300
-49% -$5.01M ﹤0.01% 3782
2022
Q2 		$12.4M Buy
1,482,500
+637,500
+75% +$8.91M ﹤0.01% 2403
2022
Q1 		$19.3M Buy
845,000
+188,600
+29% +$4.61M ﹤0.01% 2024
2021
Q4 		$18.1M Buy
656,400
+66,700
+11% +$1.79M ﹤0.01% 2145
2021
Q3 		$16.4M Sell
589,700
-128,000
-18% -$3.63M ﹤0.01% 2286
2021
Q2 		$21M Sell
717,700
-62,000
-8% -$1.88M ﹤0.01% 2017
2021
Q1 		$24.7M Buy
779,700
+372,300
+91% +$10.9M 0.01% 1723
2020
Q4 		$8.47M Sell
407,400
-89,400
-18% -$1.67M ﹤0.01% 2863
2020
Q3 		$7.72M Sell
496,800
-50,000
-9% -$861K ﹤0.01% 2600
2020
Q2 		$10M Buy
546,800
+56,600
+12% +$997K ﹤0.01% 2219
2020
Q1 		$7.6M Sell
490,200
-372,000
-43% -$8.97M ﹤0.01% 2187
2019
Q4 		$25.8M Buy
862,200
+12,500
+1% +$325K 0.01% 1257
2019
Q3 		$18.6M Sell
849,700
-81,900
-9% -$1.87M 0.01% 1540
2019
Q2 		$23.5M Sell
931,600
-74,700
-7% -$1.77M 0.01% 1281
2019
Q1 		$24.9M Sell
1,006,300
-2,093,300
-68% -$50M 0.01% 1154
2018
Q4 		$57.3M Buy
3,099,600
+478,500
+18% +$11.4M 0.03% 557
2018
Q3 		$67.3M Sell
2,621,100
-421,400
-14% -$9.65M 0.03% 591
2018
Q2 		$70.7M Sell
3,042,500
-130,900
-4% -$2.71M 0.03% 518
2018
Q1 		$50.5M Sell
3,173,400
-1,001,700
-24% -$18.6M 0.03% 595
2017
Q4 		$86.8M Buy
4,175,100
+1,873,600
+81% +$29.7M 0.05% 377
2017
Q3 		$33M Buy
2,301,500
+768,500
+50% +$11.6M 0.03% 764
2017
Q2 		$26.5M Buy
1,533,000
+319,400
+26% +$3.83M 0.02% 821
2017
Q1 		$13.4M Sell
1,213,600
-973,800
-45% -$13.4M 0.01% 1233
2016
Q4 		$31.8M Sell
2,187,400
-126,700
-5% -$2.32M 0.03% 593
2016
Q3 		$56.8M Buy
2,314,100
+475,200
+26% +$12.3M 0.06% 333
2016
Q2 		$37M Sell
1,838,900
-142,000
-7% -$4.02M 0.04% 469
2016
Q1 		$52.1M Buy
1,980,900
+1,369,500
+224% +$101M 0.07% 287
2015
Q4 		$62.1M Buy
611,400
+252,100
+70% +$28.3M 0.07% 311
2015
Q3 		$64.1M Buy
359,300
+134,000
+59% +$31.2M 0.06% 334
2015
Q2 		$50M Sell
225,300
-20,600
-8% -$4.57M 0.04% 498
2015
Q1 		$48.8M Buy
245,900
+97,600
+66% +$17.3M 0.05% 499
2014
Q4 		$21.2M Sell
148,300
-6,800
-4% -$915K 0.02% 901
2014
Q3 		$20.3M Sell
155,100
-85,200
-35% -$10.2M 0.02% 892
2014
Q2 		$30.3M Sell
240,300
-24,900
-9% -$3.18M 0.03% 601
2014
Q1 		$35M Buy
265,200
+122,200
+85% +$16.7M 0.04% 550
2013
Q4 		$16.8M Buy
143,000
+7,300
+5% +$800K 0.02% 903
2013
Q3 		$14.2M Buy
135,700
+4,600
+4% +$448K 0.02% 903
2013
Q2 		$11.3M Buy
+131,100
New +$10.3M 0.02% 993

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's BHC Position: Q1 2026 in Review

Citadel Advisors reduced its Bausch Health (BHC) stake by 39% in Q1 2026, selling an estimated $3.44M and leaving 912,171 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

Citadel Advisors first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q4 2014. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Citadel Advisors held 912,171 shares of Bausch Health worth $4.93M as of Q1 2026.
  • Citadel Advisors sold 575,124 Bausch Health shares in Q1 2026, an estimated $3.44M.
  • Bausch Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4363 holding.
  • Citadel Advisors first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Bausch Health position peaked at $142M in Q4 2014.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.